JPMorgan Chase & Co. Cuts H.B. Fuller (NYSE:FUL) Price Target to $60.00

H.B. Fuller (NYSE:FUL) had its price objective reduced by JPMorgan Chase & Co. from $70.00 to $60.00 in a research note published on Friday,Benzinga reports. They currently have an underweight rating on the specialty chemicals company’s stock.

A number of other research analysts have also weighed in on the stock. Vertical Research lowered shares of H.B. Fuller from a “buy” rating to a “hold” rating in a research report on Monday, January 6th. Citigroup cut their price objective on H.B. Fuller from $78.00 to $68.00 and set a “neutral” rating for the company in a research report on Friday, January 3rd. One analyst has rated the stock with a sell rating and four have given a hold rating to the company. According to data from MarketBeat, H.B. Fuller has a consensus rating of “Hold” and an average target price of $76.50.

H.B. Fuller Price Performance

NYSE FUL opened at $62.14 on Friday. H.B. Fuller has a fifty-two week low of $60.96 and a fifty-two week high of $87.67. The stock’s 50-day moving average is $70.82 and its two-hundred day moving average is $76.79. The firm has a market cap of $3.39 billion, a P/E ratio of 19.18, a price-to-earnings-growth ratio of 1.50 and a beta of 1.43. The company has a debt-to-equity ratio of 1.10, a current ratio of 1.89 and a quick ratio of 1.16.

H.B. Fuller (NYSE:FUL) last posted its earnings results on Wednesday, January 15th. The specialty chemicals company reported $0.92 earnings per share for the quarter, missing the consensus estimate of $1.00 by ($0.08). H.B. Fuller had a return on equity of 13.39% and a net margin of 5.15%. The company had revenue of $923.00 million during the quarter, compared to analyst estimates of $916.84 million. During the same quarter last year, the firm posted $1.32 earnings per share. The firm’s revenue for the quarter was up 2.2% compared to the same quarter last year. On average, analysts anticipate that H.B. Fuller will post 3.84 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Lord Abbett & CO. LLC lifted its stake in shares of H.B. Fuller by 79.8% in the third quarter. Lord Abbett & CO. LLC now owns 730,058 shares of the specialty chemicals company’s stock valued at $57,952,000 after buying an additional 324,056 shares during the period. Geode Capital Management LLC lifted its position in shares of H.B. Fuller by 1.5% in the 3rd quarter. Geode Capital Management LLC now owns 1,258,752 shares of the specialty chemicals company’s stock worth $99,939,000 after acquiring an additional 18,734 shares during the period. Marshall Wace LLP grew its holdings in shares of H.B. Fuller by 9.9% during the 2nd quarter. Marshall Wace LLP now owns 290,005 shares of the specialty chemicals company’s stock worth $22,319,000 after purchasing an additional 26,239 shares in the last quarter. S&CO Inc. increased its position in shares of H.B. Fuller by 0.3% during the third quarter. S&CO Inc. now owns 267,192 shares of the specialty chemicals company’s stock valued at $21,209,000 after purchasing an additional 920 shares during the period. Finally, Wesbanco Bank Inc. raised its stake in shares of H.B. Fuller by 41.2% in the fourth quarter. Wesbanco Bank Inc. now owns 13,700 shares of the specialty chemicals company’s stock valued at $924,000 after purchasing an additional 4,000 shares in the last quarter. Institutional investors own 95.93% of the company’s stock.

About H.B. Fuller

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.